Prolyl hydroxylase domain protein 3 targets Pax2 for destruction.

Article Details


Yan B, Jiao S, Zhang HS, Lv DD, Xue J, Fan L, Wu GH, Fang J

Prolyl hydroxylase domain protein 3 targets Pax2 for destruction.

Biochem Biophys Res Commun. 2011 Jun 3;409(2):315-20. doi: 10.1016/j.bbrc.2011.05.012. Epub 2011 May 14.

PubMed ID
21575608 [ View in PubMed

Prolyl hydroxylase domain proteins (PHDs) hydroxylate HIFalpha in the presence of oxygen, leading to HIFalpha proteasomal destruction. The PHDs family comprises PHD1, 2, and 3. Recent studies indicate that, in addition to HIFalpha, PHDs have other substrates. Paired box (Pax) 2, a transcription factor, was found aberrantly expressed in a variety of cancers. However, the underlying mechanisms remain unknown. Here we demonstrate that PHD3 is a negative regulator of expression of Pax2. We found that PHD3 bound to Pax2 and mediated Pax2 destruction directly. Inhibition of PHD3 hydroxylase activity led to upregulation of Pax2 protein but not mRNA level. We found that Pax2 protein was increased and PHD3 protein was decreased in colorectal cancer, and the increased Pax2 was associated with decreased PHD3. Our results suggest that PHD3 targets Pax2 for destruction. The findings may disclose a mechanism for the regulation of Pax2 expression in cancer cells.

DrugBank Data that Cites this Article

NameUniProt ID
Egl nine homolog 3Q9H6Z9Details